Mobile Menu

Liquid Biopsy: Current Status and Future Directions


Liquid biopsies is one of the technologies that has the potential to transform cancer care for good. With applications for non-invasive diagnosis and disease monitoring, overcoming the challenges that prevent the clinical utility of liquid biopsies must be addressed.

We are delighted to share with you our latest report: Liquid Biopsy: Current Status and Future Directions

This report will provide you with:

  • An overview of the current status of liquid biopsy technologies
  • Exclusive interviews with key opinion leaders on the future directions of liquid biopsy research and clinical implementation
  • Insights into the technical and social barriers preventing the clinical uptake of liquid biopsy technologies

Report Contributors:

  • Klaus Pantel, Chairman, Department of Tumor Biology, University Medical Center Hamburg-Eppendorf
  • Lauren Leiman, Executive Director, BloodPac
  • Francois Clement-Bidard, Head of Breast Cancer Group, Institut Curie
  • Hunter Underhill, Assistant Professor, University of Utah

Download Report


Share this report